A comparison of the effects of albendazole, its sulphone metabolite, and mebendazole on the viability of protoscoleces of Echinococcus granulosus in an in vitro culture system
- 31 October 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 81 (5) , 804-806
- https://doi.org/10.1016/0035-9203(87)90038-1
Abstract
The effects of albendazole, its sulphone metabolite and mebendazole on the viability of Echinococcus granulosus protoscoleces in vitro were investigated. Significant reductions in viability occurred in cultures treated with albendazole parent compound at 100 μg/litre, but lower concentrations were ineffective. The sulphone metabolite of albendazole had no significant effect at concentrations of 50 and 100 μg/litre over periods of up to 71 days. Mebendazole induced significant reductions in viability at 100 μg/litre.Keywords
This publication has 7 references indexed in Scilit:
- Penetration of albendazole sulphoxide into hydatid cysts.Gut, 1987
- Effect of albendazole sulphoxide on viability of hydatid protoscoleces in vitroTransactions of the Royal Society of Tropical Medicine and Hygiene, 1986
- Albendazole treatment of pulmonary hydatid cysts in naturally infected sheep: a study with relevance to the treatment of hydatid cysts in man.Thorax, 1985
- ALBENDAZOLE AS A POTENTIAL TREATMENT FOR HUMAN HYDATIDOSISThe Lancet, 1983
- Serum and cyst concentrations of mebendazole and flubendazole in hydatid disease.BMJ, 1982
- Bioavailability and tolerability of mebendazole in patients with inoperable hydatid diseaseTransactions of the Royal Society of Tropical Medicine and Hygiene, 1982
- Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid diseaseEuropean Journal of Clinical Pharmacology, 1982